Youping Deng to Prognosis
This is a "connection" page, showing publications Youping Deng has written about Prognosis.
Connection Strength
2.033
-
Siriwardhana C, Khadka VS, Chen JJ, Deng Y. Development of a miRNA-seq based prognostic signature in lung adenocarcinoma. BMC Cancer. 2019 Jan 08; 19(1):34.
Score: 0.480
-
Gao YP, Fan YT, Cheng XQ, Huang PN, Liu HY, Bi XJ, Sun J, Zhu Y, Zhou W, Liu YN, Deng YB. Incremental Value of NT-proBNP Over HCM-AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Clin Cardiol. 2026 Mar; 49(3):e70276.
Score: 0.197
-
Gao YP, Liu HY, Bi XJ, Sun J, Zhu Y, Zhou W, Fan YT, Cheng XQ, Huang PN, Liu YN, Deng YB. H2FPEF and HFA-PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients. ESC Heart Fail. 2025 Jun; 12(3):2225-2238.
Score: 0.184
-
Chen S, Liu F, Fu Y, Deng CK, Borgia JA, Ayman AG, Nasu M, Jijiwa M, Yang H, Gong T, Wang J, Ling Z, Wang X, Wang H, Chu Q, Deng Y. A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. Mol Cancer. 2024 Nov 06; 23(1):247.
Score: 0.180
-
Huang Z, Cheng XQ, Lu RR, Bi XJ, Liu YN, Deng YB. Incremental Prognostic Value of Carotid?Plaque-RADS Over Stenosis Degree in Relation to Stroke Risk. JACC Cardiovasc Imaging. 2025 Jan; 18(1):77-89.
Score: 0.178
-
Chen Y, Gao Z, Mohd-Ibrahim I, Yang H, Wu L, Fu Y, Deng Y. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours. Clin Transl Med. 2024 02; 14(2):e1543.
Score: 0.170
-
Chen Y, Zitello E, Guo R, Deng Y. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin Transl Med. 2021 04; 11(4):e367.
Score: 0.140
-
Zhao T, Khadka VS, Deng Y. Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses. Aging (Albany NY). 2020 07 16; 12(14):14506-14527.
Score: 0.133
-
Menor M, Zhu Y, Wang Y, Zhang J, Jiang B, Deng Y. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas. BMC Med Genomics. 2019 01 31; 12(Suppl 1):24.
Score: 0.121
-
Guo M, Lu S, Huang H, Wang Y, Yang MQ, Yang Y, Fan Z, Jiang B, Deng Y. Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. BMC Syst Biol. 2018 12 14; 12(Suppl 7):118.
Score: 0.119
-
Lu SR, Zhu Y, Zhou W, Zhang J, Deng YB, Liu YN. Incremental prognostic utility of left ventricular and left atrial strains in coronary artery disease patients with reduced systolic function. Echocardiography. 2024 01; 41(1):e15740.
Score: 0.042
-
Fan XY, Huang X, Cheng Q, Zhang J, Sun J, Tang QY, Deng YB, Bi XJ. Quantitative Assessment of Right Ventricular Function in Patients With Systemic Lupus Erythematosus Using the Novel Non-invasive Pressure-Strain Loop. Ultrasound Med Biol. 2023 05; 49(5):1337-1344.
Score: 0.040
-
Mao YH, Deng YB, Liu YN, Wei X, Bi XJ, Tang QY, Wang YB, Wang XY. Contrast Echocardiographic Perfusion Imaging in Clinical Decision-Making for Cardiac Masses in Patients With a History of Extracardiac Malignant Tumor. JACC Cardiovasc Imaging. 2019 04; 12(4):754-756.
Score: 0.030
-
Zhu Y, Deng YB, Liu YN, Bi XJ, Sun J, Tang QY, Deng Q. Use of carotid plaque neovascularization at contrast-enhanced US to predict coronary events in patients with coronary artery disease. Radiology. 2013 Jul; 268(1):54-60.
Score: 0.020